Front. Bioeng. Biotechnol.Frontiers in Bioengineering and BiotechnologyFront. Bioeng. Biotechnol.2296-4185Frontiers Media S.A.160712510.3389/fbioe.2025.1607125Bioengineering and BiotechnologyCorrectionCorrigendum: Redefining vascular repair: revealing cellular responses on PEUU—gelatin electrospun vascular grafts for endothelialization and immune responses on in vitro modelsRodríguez-Soto et al.10.3389/fbioe.2025.1607125Rodríguez-SotoMaría A.1Riveros-CortésAlejandra1Orjuela-GarzónIan C.1Fernández-CalderónInés María1RodríguezCristian F.1Suárez VargasNatalia1OstosCarlos2Muñoz CamargoCarolina1CruzJuan C.1KimSeungil3D'AmoreAntonio3WagnerWilliam R.3BriceñoJuan C.14*1Department of Biomedical Engineering, Universidad de los Andes, Bogotá, Colombia2Instituto de Química, Facultad de Ciencias Exactas y Naturales, Universidad de Antioquia, Medellín, Colombia3McGowan Institute for Regenerative Medicine and Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States4Department of Congenital Heart Disease and Cardiovascular Surgery, Fundación CardioInfantil Instituto de Cardiología, Bogotá, Colombia
Edited and reviewed by:Wolfgang Holnthoner, AUVA Research Centre, Austria
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Corrigendum on Redefining vascular repair: revealing cellular responses on PEUU—gelatin electrospun vascular grafts for endothelialization and immune responses on in vitro models by Rodríguez-Soto MA, Riveros-Cortés A, Orjuela-Garzón IC, Fernández- Calderón IM, Rodríguez CF, Vargas NS, Ostos C, Camargo CM, Cruz JC, Kim S, D’Amore A, Wagner WR and Briceño JC (2024). Front. Bioeng. Biotechnol. 12:1410863. doi: 10.3389/fbioe.2024.1410863tissue engineered vascular graftsregenerative medicinebiomaterialsinflammatory responseimmunomodulationM1/M2 macrophage polarizationendothelializationcell signalingMinisterio de Ciencia, Tecnología e Innovación10.13039/100022965section-at-acceptanceTissue Engineering and Regenerative Medicine
In the published article, there was an error in Figure 9 as published. The image labeled as “2D control Day 1 panel of Phalloidin (AF 488)” was mistakenly similar to the image labeled as “ML + P + P Lumen Day 7 panel of Phalloidin (AF 488) due to a mislabeling during file organization.” The corrected Figure 9 and its caption “Endothelialization potential of ML + P + P with HUVECs seeded on the luminal surface. (A) Phalloidin staining at days 1 and 7 compared with a 2D control on a glass slide. (B) SEM images of Endothelial cell lining. Black arrows highlight cells and cell nuclei, yellow arrows indicate cell boundaries, and red arrows correspond to cracks in the fixed cell monolayer resulting from sample processing; beneath this layer, electrospun fibers are visible. (C) Percentage of covered surface area by HUVECs, data normalized from with 2D control. (D) DNA quantification at 7 days. (E) RNA expression profile. (E) VEGF and NO release. (F) Intracellular ROS production. (Mean ± SD) where, ns = no significant *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.” appear below.
Endothelialization potential of ML + P + P with HUVECs seeded on the luminal surface. (A) Phalloidin staining at days 1 and 7 compared with a 2D control on a glass slide. (B) SEM images of Endothelial cell lining. Black arrows highlight cells and cell nuclei, yellow arrows indicate cell boundaries, and red arrows correspond to cracks in the fixed cell monolayer resulting from sample processing; beneath this layer, electrospun fibers are visible. (C) Percentage of covered surface area by HUVECs, data normalized from with 2D control. (D) DNA quantification at 7 days. (E) RNA expression profile. (E) VEGF and NO release. (F) Intracellular ROS production. (Mean ± SD) where, ns = no significant *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.